Table 2.
GRADE assessment and evidence profile.
COMPARISON: women with PCOS versus controls | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Quality assessment |
No. participants |
|||||||||||
No. studies | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other | PCOS | Control | Effect estimate: Hedges’ g [95% CI] | Favours | Certainty | Importance |
Outcome: total sexual function | ||||||||||||
22 | Case control, cross-sectional | Serious1 | Serious2 | Not serious | Not serious | None | 1630 | 1684 | −0.66 [−1.20, −0.12] | Controls |
|
CRITICAL |
Outcome: sexual desire | ||||||||||||
21 | Case control, cross-sectional | Serious1 | Serious2 | Not serious | Not serious | None | 1735 | 1977 | −0.21 [−0.39, 0.02] | Controls |
|
CRITICAL |
Outcome: sexual arousal | ||||||||||||
19 | Case control, cross-sectional | Serious1 | Serious2 | Not serious | Not serious | None | 1577 | 1811 | −0.33 [−0.50, −0.16] | Controls |
|
CRITICAL |
Outcome: lubrication | ||||||||||||
19 | Case control, cross-sectional | Serious1 | Serious2 | Not serious | Not serious | None | 1549 | 1801 | −0.50 [−0.74, −0.26] | Controls |
|
IMPORTANT |
Outcome: orgasm | ||||||||||||
20 | Case control, cross-sectional | Serious1 | Serious2 | Not serious | Not serious | None | 1641 | 1780 | −0.35 [−0.52, −0.18] | Controls |
|
IMPORTANT |
Outcome: satisfaction | ||||||||||||
24 | Case control, cross-sectional | Serious1 | Serious2 | Not serious | Not serious | None | 1962 | 2246 | −0.26 [−0.37, −0.15] | Controls |
|
IMPORTANT |
Outcome: pain | ||||||||||||
18 | Case control, cross-sectional | Serious1 | Serious2 | Not serious | Not serious | None | 1485 | 1732 | −0.36 [−0.59, 0.13] | Controls |
|
IMPORTANT |
Outcome: VAS sexual thoughts and fantasies | ||||||||||||
3 | Case control, cross-sectional | Serious1 | Not applicable | Not applicable | Serious3 | None | 225 | 50 | NA | No difference |
|
IMPORTANT |
Outcome: VAS sex life satisfaction | ||||||||||||
3 | Case control, cross-sectional | Serious1 | Not applicable | Not applicable | Serious3 | None | 225 | 50 | NA | Controls |
|
IMPORTANT |
Outcome: VAS importance of satisfying sex life | ||||||||||||
3 | Case control, cross-sectional | Serious1 | Not applicable | Not applicable | Serious3 | None | 225 | 50 | NA | No difference |
|
IMPORTANT |
Outcome: VAS pain during intercourse | ||||||||||||
2 | Case control, cross-sectional | serious1 | Not applicable | Not applicable | Serious3 | None | 105 | 50 | NA | No difference |
|
IMPORTANT |
Outcome: VAS body hair impact | ||||||||||||
4 | Case control, cross-sectional | serious1 | not applicable | not applicable | serious3 | none | 297 | 50 | NA | Controls |
|
IMPORTANT |
Outcome: VAS social contact impact | ||||||||||||
4 | Case control, cross-sectional | serious1 | not applicable | not applicable | serious3 | none | 297 | 50 | NA | Controls |
|
IMPORTANT |
Outcome: VAS sexual attractiveness | ||||||||||||
4 | Case control, cross-sectional | serious1 | not applicable | not applicable | serious3 | none | 297 | 50 | NA | Controls |
|
IMPORTANT |
GRADE, Grading of Recommendations, Assessment, Development and Evaluations; VAS, visual analogue scale; NA, not applicable.
Downgraded once due to most studies being of moderate risk of bias.
Downgraded once due to high statistical heterogeneity.
Downgraded once due to small sample size of control group and the same controls used across all studies.